Alkem Foundation Backs IIT Bombay In Setting Up Research Hub For Regenerative Medicine
Mumbai: The Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories Ltd., has announced a significant collaboration with the Indian Institute of Technology Bombay (IIT Bombay) to establish a state-of-the-art research center focused on immuno-therapeutics and regenerative medicines. This partnership aims to accelerate innovation, advanced research, and skill development in therapeutic areas that address critical unmet medical needs.
Funding the Alkem Centre for Advanced Research and Development
Under this collaboration, the Alkem Foundation will finance the creation of the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines on the IIT Bombay campus. The foundation plans to allocate approximately 20–25% of its cumulative CSR obligations over the next seven years to support this initiative. This commitment marks a landmark CSR-driven industry-academia partnership in India.
Combining Expertise for Innovation
This strategic alliance aims to merge Alkem’s extensive pharmaceutical expertise with IIT Bombay’s academic and research strengths in biomedical engineering, biosciences, and translational research. The center is envisioned to create an innovation-driven ecosystem that fosters research and development (R&D) in complex therapy areas while addressing gaps in infrastructure, talent, and translational capabilities in high-precision medicine.
Advancing Research and Training in High-Precision Healthcare
The initiative aligns with IIT Bombay’s multidisciplinary approach to healthcare research, integrating biology, engineering, and data science to improve human health outcomes. The research facility will focus on emerging areas such as:
- Gene editing
- Biomaterials
- Advanced therapeutic technologies
The center will support the development of next-generation immuno-therapeutics and regenerative medicines. Additionally, it will serve as a training and incubation hub for clinician-scientists and biotech entrepreneurs, leveraging mentorship from Alkem and IIT Bombay experts, as well as global advisors from leading international universities. This collaborative effort aims to enhance India’s translational research capacity.
Statements from Leadership
Madhurima Singh, Executive Director and Chairperson of the CSR and Sustainability Committee at Alkem, emphasized the importance of scientific advancement in addressing unmet medical needs. She stated, “At Alkem, we recognize the importance of scientific advancement in addressing unmet medical needs. Through this collaboration with IIT Bombay, we aim to channel CSR efforts toward impactful R&D that supports innovation and self-reliance in healthcare.”
Prof. Shireesh B. Kedare, Director of IIT Bombay, added, “Our partnership with Alkem Foundation will enable us to translate scientific research into practical healthcare solutions. It will foster affordable, high-impact therapies while strengthening India’s position in global healthcare innovation.”
A Model for CSR-Led Healthcare Innovation
This collaboration between Alkem Foundation and IIT Bombay seeks to establish a national model for CSR-led R&D partnerships. It highlights India’s commitment to advancing affordable, cutting-edge healthcare solutions and positions the country as a global leader in applied biotechnology.
Conclusion
In summary, the establishment of the Alkem Centre for Advanced Research and Development represents a significant step forward in the field of regenerative medicine and immuno-therapeutics in India. By combining the strengths of industry and academia, this initiative is poised to make a lasting impact on healthcare innovation and research.
Note: This article is based on information available as of October 2023 and aims to provide an overview of the collaboration between Alkem Foundation and IIT Bombay.
